Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DMIS75V)

Drug Name

MTL-CEPBA Drug Info

Indication

Disease Entry	ICD 11	Status	REF
Hepatocellular carcinoma	2C12.02	Phase 1/2	[1]

Cross-matching ID

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
CEBPA messenger RNA (CEBPA mRNA)	TT5LWG1	CEBPA_HUMAN	Activator	[2]

------------------------------------------------------------------------------------

References

1	Clinical pipeline report, company report or official report of MiNA Therapeutics.
2	MTL-CEBPA, a Small Activating RNA Therapeutic Upregulating C/EBP-alpha, in Patients with Advanced Liver Cancer: A First-in-Human, Multicenter, Open-Label, Phase I Trial. Clin Cancer Res. 2020 Aug 1;26(15):3936-3946.